CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.

Deng W, Xu M, Meng Q, Li Z, Qiu X, Yin S, Sun D, Dai C, Liu Y

Open source

DOI
10.1093/rheumatology/kez112
Published
2019 Nov 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/kez112,
  title = {CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.},
  author = {Deng W and Xu M and Meng Q and Li Z and Qiu X and Yin S and Sun D and Dai C and Liu Y},
  year = {2019},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/kez112},
  url = {https://doi.org/10.1093/rheumatology/kez112}
}

RIS

TY  - JOUR
TI  - CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.
AU  - Deng W
AU  - Xu M
AU  - Meng Q
AU  - Li Z
AU  - Qiu X
AU  - Yin S
AU  - Sun D
AU  - Dai C
AU  - Liu Y
PY  - 2019
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/kez112
UR  - https://doi.org/10.1093/rheumatology/kez112
ER  - 

APA

W, D., M, X., Q, M., Z, L., X, Q., S, Y., D, S., C, D., & Y, L. (2019). CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/kez112

Source records